Latest Strategic Pivot News

Loyal Metals reveals a strategic pivot to copper with its Highway Reward mine, tapping into remnant resources and AI-driven exploration to capitalize on soaring commodity prices.

Loyal Metals has validated an extensive historical drilling dataset at Queensland's Highway Reward Mine, revealing significant unmined copper-gold mineralisation and setting the stage for a new exploration phase backed by $5.8 million in funding.

Cyclone Metals has restructured its management, appointing Paul Berend as CEO of the Iron Bear Project while the Board temporarily oversees corporate functions during the search for a new CEO.

Shriro Holdings has reversed its plan to delist from the ASX and scrap a $5 million share buy-back, now considering a special dividend to reward shareholders.

Global Lithium Resources has sold its entire 264 million shareholding in Kairos Minerals for $7.1 million, boosting its cash reserves to $21.8 million. The company will now focus these funds on advancing its flagship Manna Lithium Project.

Magnum Mining & Exploration is moving forward with plans to establish a modular processing hub for critical minerals in Nevada, targeting antimony and rare earth elements to support U.S. supply chains.

JAYRIDE Group Limited has confirmed Randy Prado as CEO and Ram Navaratnam as Finance Director, cementing leadership as it advances its SaaS mobility platform with pilots in Southeast Asia.

Equinox Resources has agreed to sell its Alturas Antimony Project in British Columbia to Maxus Mining, freeing up capital and focus for its core iron ore ambitions in Western Australia.

My Foodie Box Limited has raised $500,000 through unsecured promissory notes to support its transformation into Tarrina Resources and relisting on the ASX as a resource exploration company.

Blue Star Helium has decided not to exercise its purchase option on key Colorado helium assets after thorough evaluation, signaling a strategic pivot in its growth approach.

Pathkey.AI has upgraded its TrialKey platform to include drug-level molecular and pharmacokinetic features, enhancing clinical trial predictions and opening doors to AI-driven drug discovery.

Buxton Resources has strategically refined its exploration portfolio, acquiring promising copper and gold projects while divesting less aligned assets to accelerate discovery potential and shareholder value.